肾上腺素对院外心脏骤停可除颤与不可除颤心律的疗效:PACA与PARAMEDIC-2随机对照试验结果
本研究基于PARAMEDIC-2随机安慰剂对照试验,比较不同初始心律下肾上腺素与安慰剂对自主循环恢复、生存和神经功能预后的影响,并合并PACA试验进行Meta分析。结果显示,不可除颤心律患者自主循环恢复的调整OR为6.5(95%CI 5.6-7.6),可除颤心律为2.3(95%CI 1.9-2.9)。出院生存的调整OR在不可除颤心律为2.5(1.3-4.8),可除颤心律为1.3(0.9-1.8),交互作用P=0.065。神经功能预后的调整OR分别为1.8(0.8-4.1)和1.1(0.8-1.6),交互作用P=0.295。Meta分析结果相似。
要点
- 不可除颤心律患者自主循环恢复率:肾上腺素组33.4% vs 安慰剂组7.4%,调整OR 6.5(95%CI 5.6-7.6)。
- 可除颤心律患者自主循环恢复率:肾上腺素组48.7% vs 安慰剂组29.6%,调整OR 2.3(95%CI 1.9-2.9)。
- 出院生存调整OR:不可除颤心律2.5(95%CI 1.3-4.8),可除颤心律1.3(95%CI 0.9-1.8),交互作用P=0.065。
- 出院神经功能预后调整OR:不可除颤心律1.8(95%CI 0.8-4.1),可除颤心律1.1(95%CI 0.8-1.6),交互作用P=0.295。
- Meta分析合并PACA与PARAMEDIC-2试验,结果与主分析相似。
适用人群与场景
- 纳入PARAMEDIC-2随机安慰剂对照试验的患者,初始心律 known 者中安慰剂组3929例(98.2%)、肾上腺素组3919例(97.6%)。
研究设计与关键结果
- 研究类型:基于PARAMEDIC-2随机安慰剂对照试验的二次分析,并合并PACA试验进行Meta分析。
- 不可除颤心律患者自主循环恢复率:肾上腺素组1002/3003(33.4%) vs 安慰剂组222/3005(7.4%),调整OR 6.5(95%CI 5.6-7.6)。
- 可除颤心律患者自主循环恢复率:肾上腺素组349/716(48.7%) vs 安慰剂组208/702(29.6%),调整OR 2.3(95%CI 1.9-2.9)。
- 出院生存调整OR:不可除颤心律2.5(95%CI 1.3-4.8),可除颤心律1.3(95%CI 0.9-1.8),交互作用P=0.065。
- 出院神经功能预后调整OR:不可除颤心律1.8(95%CI 0.8-4.1),可除颤心律1.1(95%CI 0.8-1.6),交互作用P=0.295。
- Meta分析结果与主分析相似。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析和Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于初始不可除颤心律的院外心脏骤停患者,与安慰剂相比,肾上腺素可提高自主循环恢复率(33.4% vs 7.4%,调整OR 6.5),出院生存调整OR 2.5(95%CI 1.3-4.8)。
- 对于初始可除颤心律患者,肾上腺素对自主循环恢复的获益较小(调整OR 2.3),出院生存调整OR 1.3(95%CI 0.9-1.8),神经功能预后调整OR 1.1(95%CI 0.8-1.6)。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Previous research suggests there may be differences in the effects of adrenaline related to the initial cardiac arrest rhythm. The aim of this study was to assess the effect of adrenaline compared with placebo according to whether the initial cardiac arrest rhythm was shockable or non-shockable.
METHODS: Return of spontaneous circulation (ROSC), survival and neurological outcomes according to the initial arrest rhythm were compared amongst patients enrolled in the PARAMEDIC-2 randomised, placebo controlled trial. The results of the PARAMEDIC-2 and PACA out of hospital cardiac arrest trials were combined and meta-analysed.
RESULTS: The initial rhythm was known for 3929 (98.2%) in the placebo arm and 3919 (97.6%) in the adrenaline arm. The effect on the rate of ROSC of adrenaline relative to placebo was greater in patients with non-shockable cardiac rhythms (1002/3003 (33.4%) versus 222/3005 (7.4%), adjusted OR: 6.5, (95% CI 5.6-7.6)) compared with shockable rhythms 349/716 (48.7%) versus (208/702 (29.6%), adjusted OR: 2.3, 95%CI: 1.9-2.9)). The adjusted odds ratio for survival at discharge for non-shockable rhythms was 2.5 (1.3, 4.8) and 1.3 (0.9, 1.8) for shockable rhythms (P value for interaction 0.065) and 1.8 (0.8-4.1) and 1.1 (0.8-1.6) respectively for neurological outcome at discharge (P value for interaction 0.295). Meta-analysis found similar results.
CONCLUSION: Relative to placebo, the effects of adrenaline ROSC are greater for patients with an initially non-shockable rhythm than those with a shockable rhythms. Similar patterns are observed for longer term survival outcomes and favourable neurological outcomes, although the differences in effects are less pronounced. ISRCTN73485024.
参考来源
- Perkins GD, Kenna C, Ji C, et al. The effects of adrenaline in out of hospital cardiac arrest with shockable and non-shockable rhythms: Findings from the PACA and PARAMEDIC-2 randomised controlled trials. Resuscitation. 2019. PMID: 31116964. doi:10.1016/j.resuscitation.2019.05.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。